Bio-Rad Laboratories (BIO) Share-based Compensation Growth (3y) (2012 - 2025)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) Share-based Compensation Growth (3y) (2012 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -1.05% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 25.99% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -11.69% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -7.67% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 65.20% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 141.16% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -17.55% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -4.23% |
| Sep 30, 2025 | -1.73% |
| Dec 31, 2024 | 3.02% |
| Sep 30, 2024 | 5.99% |
| Dec 31, 2023 | 9.61% |
| Sep 30, 2023 | 13.76% |
| Dec 31, 2022 | 21.07% |
| Sep 30, 2022 | 19.94% |
| Jun 30, 2022 | 20.36% |
| Mar 31, 2022 | 16.67% |
| Dec 31, 2021 | 20.37% |
| Sep 30, 2021 | 22.65% |
| Jun 30, 2021 | 22.51% |
| Mar 31, 2021 | 25.64% |
| Dec 31, 2020 | 21.93% |
| Sep 30, 2020 | 21.41% |
| Jun 30, 2020 | 19.33% |
| Mar 31, 2020 | 21.56% |
| Dec 31, 2019 | 23.75% |
| Sep 30, 2019 | 22.83% |